NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported that its fourth quarter 2013 revenues climbed 6 percent year over year with high- to mid-single digit growth across all three of its reporting segments.

The firm reported total revenues of $3.47 billion for the three months ended Dec. 31, compared to $3.26 billion for the fourth quarter of 2012. It beat the consensus analyst estimate of $3.31 billion for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.